Picture Kentro Design Corporate and Web Design Berlin 600x60px
Organisation › Details

Biodesix Inc.

Biodesix is a molecular diagnostics company advancing the development of innovative products for personalizing medicine. The company provides physicians with diagnostic tests for earlier disease detection, more accurate diagnosis, disease monitoring and better therapeutic guidance, which may lead to improved patient outcomes. Biodesix discovers, develops and commercializes multivariate protein diagnostics based on their proprietary mass spectrometry-based discovery platform. VeriStrat, a multivariate serum protein test, is Biodesix' first product developed with this technology. The commercially available test provides oncologists with information to help them select between erlotinib and single-agent chemotherapy for advanced lung cancer patients. Tests are processed in Biodesix' CLIA-certified laboratory and results are reported in less than 72 hours. In addition to developing novel diagnostics independently, the company also partners with biotechnology and pharmaceutical companies to develop companion diagnostics to improve utility of therapeutic agents. For more information on VeriStrat, please visit *


Period Start 2005-01-01 established
Products Industry molecular diagnostics
  Industry 2 MALDI-TOF mass spectrometry technology
Persons Person Brunel, David (Biodesix 200810 CEO)
  Person 2 Hutton, Scott (Biodesix 201803– COO before Spectranetics + Medtronic)
Region Region Boulder, CO
  Country United States (USA)
  Street 2970 Wilderness Place
  City 80301 Boulder, CO
  Tel +1-303-417-0500
    Address record changed: 2018-07-24
Basic data Employees D: 101 to 500 (2015-10-09)
    * Document for �About Section�: Biodesix, Inc.. (4/11/13). "Press Release: Biodesix Closes Series D Financing". Boulder, CO.
Record changed: 2019-01-29


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Biodesix Inc.

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px

» top